… or recurrent, ALK-positive non-small cell lung cancer (NSCLC).
Roche's Phase … with advanced ALK-positive non-small cell lung cancer (NSCLC), revealed a 66 percent … advancement for people with ALK-positive lung cancer, and we plan to discuss …
No comments:
Post a Comment